C106 MONEY DON'T MATTER TONIGHT: PULMONARY HYPERTENSION ASSESSMENT, PROGNOSTICATION, AND TREATMENT: Determinants Of Health Related Quality Of Life In Pah: Data From The Pulmonary Hypertension Association Registry

PHAR Study Group Corresponding author's email: zamanian@stanford.edu Rationale: Pulmonary hypertension (PAH) is a debilitating and fatal cardiopulmonary disorder with a high impact on daily life quality. PAH is characterized by non-specific but debilitating symptoms such as breathlessness, decr...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Zamanian, R T, Badesch, D, Bull, T M, DeMarco, T, Feldman, J, Fineman, J, d, H J, Gray, M P, Grinnan, D, Klinger, J R, McConnell, J W, Rosenzweig, E, Santos, L, Sager, J
Format: Article
Language:English
Subjects:
Medical prognosis
Patients
Pulmonary hypertension
Quality of life
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PHAR Study Group Corresponding author's email: zamanian@stanford.edu Rationale: Pulmonary hypertension (PAH) is a debilitating and fatal cardiopulmonary disorder with a high impact on daily life quality. PAH is characterized by non-specific but debilitating symptoms such as breathlessness, decreased exercise tolerance, depression, and fatigue, resulting in a reduced health-related quality of life (HRQoL). [...]recently CAMPHOR was the only available PH-specific questionnaire.
ISSN:1073-449X
1535-4970